MétaCan
Menu
Back to cohort
Record W4410502655 · doi:10.1093/sleep/zsaf090.0774

0774 Glucagon-Like Peptide 1 Receptor Agonists for Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis

2025· review· en· W4410502655 on OpenAlexaff
Stanley Sau Ching Wong, Nicholas Fabiano, Carl Zhou, Brandon Luu, Risa Shorr, Marco Solmi, Ishrat Husain, Michael Mak

Bibliographic record

VenueSLEEP · 2025
Typereview
Languageen
FieldMedicine
TopicObstructive Sleep Apnea Research
Canadian institutionsCentre for Addiction and Mental HealthUniversity of OttawaUniversity of Toronto
Fundersnot available
KeywordsObstructive sleep apneaMeta-analysisMedicineGlucagon-like peptide 1 receptorGlucagon-like peptide-1Sleep apneaReceptorSleep (system call)Internal medicinePolysomnographyEndocrinologyApneaAgonistDiabetes mellitusComputer scienceType 2 diabetes

Abstract

fetched live from OpenAlex

Abstract Introduction Glucagon-like peptide-1 (GLP-1) receptor agonists have gained recent popularity in its usage for weight loss in people with diabetes and obesity. There is also emerging evidence of its usage for treating obstructive sleep apnea (OSA) which can be caused by or worsened by obesity. However, there is limited synthesized evidence for the usage of GLP-a receptor agonists for people with OSA. Methods We performed a PRISMA compliant systematic review and meta-analysis of the effects of GLP-1 receptor agonists in people with OSA. MEDLINE, EMBASE, Cochrane Library, and PsycINFO were searched up to June 30th, 2024. Randomized controlled trials (RCT) investigating the usage of any GLP-1 receptor agonists in people with OSA that reported OSA symptom outcomes as measured by the apnea-hypopnea index (AHI) were included. Standardized mean difference (SMD) measured effect size. Q and I2 tests measured heterogeneity. Cochrane Risk of Bias Tool 2 assessed risk of bias. Results Six studies were included which consisted of 1023 participants with moderate to severe OSA. 516 participants received GLP-1 receptor agonist treatment for their OSA with 507 in the control group (receiving either placebo or continuous positive airway pressure (CPAP)). GLP-1 receptor agonist therapy for OSA when compared to placebo groups had an medium effect size of SMD = - 0.601 (95% CI: - 0.969 to - 0.233, p = 0.001). When compared to CPAP treatment, there was no significant difference in AHI differences post-treatment (p = 0.297). Conclusion This systematic review and meta-analysis synthesizes the current evidence which supports the potential usage of GLP-1 receptor agonists for the treatment of OSA. This pharmaceutical treatment option would increase the treatment options available for people with OSA. However, the literature is limited by the few RCTs available, small sample sizes, and lack of long-term follow-up data. Further studies are needed in this area. Support (if any)

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.003
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow), Meta-epidemiology (broad)
Consensus categoriesMeta-epidemiology (narrow)
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.661
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0020.003
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0220.009
Bibliometrics0.0020.004
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.061
GPT teacher head0.373
Teacher spread0.312 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; both teacher heads agree on what is shown here.

Study designMeta-analysis
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueSLEEPSame topicObstructive Sleep Apnea ResearchFrench-language works237,207